Longtime runner Annie Saunders didn’t let a 2021 diagnosis of multiple sclerosis sideline her passions. If anything, the 40-year-old Irwin native pushes harder — through weakness and imbalance caused ...

Should multiple sclerosis (MS) patients stop disease-modifying treatment (DMT) as they get older? The answer depends on several factors, noted John Corboy, MD, of the Rocky Mountain MS Center at the ...

As recently as the ‘90s, when patients arrived with all the typical symptoms — memory loss, double vision, fatigue — neurologists often avoided confirming what they most suspected: that the patient ...

Multiple sclerosis (MS) treatment could be on the brink of a significant breakthrough thanks to innovative research by Immunic Therapeutics. Speaking to Fierce Pharma, CEO Daniel Vitt shares insights ...

PARIS — The first real guidelines on the use of disease-modifying therapies in multiple sclerosis (MS) have been released by a European joint venture between the European Committee for Research and ...

MS treatments during pregnancy do not seem to increase the risk of neurodevelopmental disorders in exposed children, a study ...

Physical exercise may help reduce inflammation in MS by changing immune activity, a study in mice and patients suggests.

A generation ago, most people with multiple sclerosis could expect to rely on walkers and wheelchairs or be limited to their bed within 15 years of diagnosis. Today, UC San Francisco’s discoveries are ...

Cladribine, a nucleotide (deoxyadenosine) analogue, inhibits deoxyribonucleic acid (DNA) synthesis in proliferating lymphocytes, causing DNA damage and depleting their number by apoptosis and ...

People across the country are lacing up their sneakers for a cause—supporting those living with multiple sclerosis (MS), a ...